Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peyser

Showing results (551-560 of 677) with videos related to

Pageof 68
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Circulation. Cardiovascular Genetics|March 26, 2015
Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter StudyMarco Dauriz, Bianca C Porneala, Xiuqing Guo, et al.
Research Square|July 3, 2026
COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced ProtectionJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.
American Journal of Human Genetics|July 1, 2014
Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcificationShurjo K Sen, Kimberly C Boelte, Jennifer J Barb, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
A common allele of HLA mediates asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Tasneem Yusufali, Joseph J Sabatino, et al.
Hepatology Communications|July 24, 2019
Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without DiabetesLlilda Barata, Mary F Feitosa, Lawrence F Bielak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 25, 2023
Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian RandomizationJie Zheng, Eleanor Wheeler, Maik Pietzner, et al.
Diabetes|April 3, 2019
A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver DiseaseJiantao Ma, Jana Nano, Jingzhong Ding, et al.
Cell Genomics|January 17, 2022
Association of mitochondrial DNA copy number with cardiometabolic diseasesXue Liu, Ryan J Longchamps, Kerri L Wiggins, et al.
Neuroimage|February 8, 2022
Brain simulation as a cloud service: The Virtual Brain on EBRAINSMichael Schirner, Lia Domide, Dionysios Perdikis, et al.
Pageof 68

Showing results (551-560 of 677) with videos related to

Sort By:
Pageof 68
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Circulation. Cardiovascular Genetics|March 26, 2015
Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter StudyMarco Dauriz, Bianca C Porneala, Xiuqing Guo, et al.
Research Square|July 3, 2026
COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced ProtectionJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.
American Journal of Human Genetics|July 1, 2014
Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcificationShurjo K Sen, Kimberly C Boelte, Jennifer J Barb, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
A common allele of HLA mediates asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Tasneem Yusufali, Joseph J Sabatino, et al.
Hepatology Communications|July 24, 2019
Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without DiabetesLlilda Barata, Mary F Feitosa, Lawrence F Bielak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 25, 2023
Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian RandomizationJie Zheng, Eleanor Wheeler, Maik Pietzner, et al.
Diabetes|April 3, 2019
A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver DiseaseJiantao Ma, Jana Nano, Jingzhong Ding, et al.
Cell Genomics|January 17, 2022
Association of mitochondrial DNA copy number with cardiometabolic diseasesXue Liu, Ryan J Longchamps, Kerri L Wiggins, et al.
Neuroimage|February 8, 2022
Brain simulation as a cloud service: The Virtual Brain on EBRAINSMichael Schirner, Lia Domide, Dionysios Perdikis, et al.
Pageof 68